Meeting
2016 ASCO Annual Meeting
Plasma caveolin-1 to predict disease reclassification in men with early stage prostate cancer in active surveillance.
Authors
Spyridon P Basourakos
The University of Texas MD Anderson Cancer Center, Houston, TX
Spyridon P Basourakos , John W. Davis , Brian Francis Chapin , John Francis Ward , Curtis Alvin Pettaway , Louis L. Pisters , Mary F. Achim , Xuemei Wang , Seungtaek Choi , Deborah A. Kuban , Patricia Troncoso , Christopher Logothetis , Timothy C. Thompson , Jeri Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Clinical Trial Registration Number
NCT00490763
Citation
J Clin Oncol 34, 2016 (suppl; abstr 5052)
DOI
10.1200/JCO.2016.34.15_suppl.5052
Abstract #
5052
Poster Bd #
309
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Persistent need for systematic biopsy for those on active surveillance for early-stage prostate cancer.
First Author: Mary Fakunle
Poster
2021 Genitourinary Cancers Symposium
p2PSA-associated parameters are significant predictors of reclassification of first-year protocol biopsy on active surveillance for early-stage prostate cancer patients: From the PRIAS-JAPAN study.
First Author: Takuma Kato
Poster
2019 Genitourinary Cancers Symposium
Molecular characterization of longitudinally tracked prostate cancer foci in men on active surveillance for low risk disease.
First Author: Jeffrey J. Tosoian
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg